NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus aureus

Carrasco, Javiera; Sandoval, Felipe; Schuh, Christina; Lagos, Carlos; Morales, Javier; Arriagada, Francisco; Ortiz, Andrea

Publication:
NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus aureus

Files

NLC-Based Rifampicin Delivery System Development and.pdf (1.23 MB)

Date

2025

Type:

Article

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

0

Vistas totales

1

Métricas

Gestores bibliográficos

Authors

item.page.doiurl

https://doi.org/10.3390/pharmaceutics17060799

URI

https://hdl.handle.net/11447/11027

item.page.accessRights

Acceso Abierto

Abstract

Background/Objectives: Rifampicin is a typical antibiotic used for the treatment of Staphylococcus aureus (S. aureus) infections; however, its clinical utility is limited by poor aqueous solubility, c...

Citation

Carrasco-Rojas J, Sandoval FI, Schuh CMAP, Lagos CF, Morales JO, Arriagada F, Ortiz AC. NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus aureus. Pharmaceutics. 2025 Jun 19;17(6):799. doi: 10.3390/pharmaceutics17060799.

Keywords

HepG2 cell , Staphylococcus aureus , Antibiotic , Drug release , Nanostructured lipid carrier

Estadísticas de uso

1 0,8 0,5 0,3 0